NCT00326274 is a Phase 3 clinical trial of Helioblock® SX Cream in Sunburn, sponsored by Loreal USA.

Who is sponsoring NCT00326274?

NCT00326274 is sponsored by Loreal USA.

What drugs are being tested in NCT00326274?

Interventions in NCT00326274: Helioblock® SX Cream.

Is NCT00326274 still recruiting?

NCT00326274 is currently completed. Last updated 10 February 2009.

Last reviewed 2009-02-10 · How we verify

NCT00326274

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream

Completed Phase 3 Last updated 10 February 2009

What this trial tests

Phase 3 trial testing Helioblock® SX Cream in Sunburn. Completed in 1 November 2006.

Timeline

1 May 2006

Primary endpoint
1 November 2006

1 November 2006

Quick facts

Lead sponsor	Loreal USA
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Start date	1 May 2006
Primary completion	1 November 2006
Estimated completion	1 November 2006
Sites	1 location across United States

Drugs / interventions tested

Helioblock® SX Cream

Conditions studied

Sunburn — all drugs for Sunburn →

Sponsor

Loreal USA — full company profile →

Who can join

Adults 6 Months to 12, any sex, with Sunburn.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Long term safety after 6 months intermittent use in a pediatric population
Time frame: 6 months

Sponsor's own description

The purpose of this study is to determine the safety potential of Helioblock® SX Cream as a sunscreen product in long term intermittent use conditions among pediatric subjects.. Each subject will be enrolled to participate for six months. The test product should be applied every day that outdoor activities are planned, prior to any significant sun exposure during out-door activities (such as the beach, outdoor sport activities), or whenever the subject needs to be protected against sunburn or other damage due to the sun. A minimum of 14 days test product use and sun exposure is required.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sunburn

Currently open trials in the same condition.

NCT06720402 — Pediatricians and Family Physicians Knowledge and Awareness on Sun Protection · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00326274 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Loreal USA
Last refreshed: 10 February 2009

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00326274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing